# R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis

> **NCT00140218** · PHASE1,PHASE2 · COMPLETED · sponsor: **Bennett, James P., Jr., M.D., Ph.D.** · enrollment: 30 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** R(+) pramipexole dihydrochloride monohydrate

## Key facts

- **NCT ID:** NCT00140218
- **Lead sponsor:** Bennett, James P., Jr., M.D., Ph.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2007-01
- **Final completion:** 2006-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140218, "R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00140218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*